Login
$EHTH
$0.42 +$0.04 (9.75%) After hours

Company Executives

Officer Age In this role 2025 pay Source
Derrick A. Duke Also a director
Chief Executive Officer and Director
59 Not stated $3,262,665
John J. Dolan
Senior Vice President, Chief Financial Officer
58 Since 2024
2 years
$1,228,724
Michelle M. Barbeau
Chief Revenue Officer
48 Since 2024
2 years
$1,183,167
Gavin G. Galimi
SVP, General Counsel & Secr.
Title from the Form 4 dated Oct 10, 2026
53 Not stated Not reported

Each officer opens the passage of the filing that names them. A title that changed since the list comes from the officer's latest Form 3, 4 or 5, and its start year is not stated there. "Not stated" means the filing does not say. Pay is the proxy's Summary Compensation Table, which reports only the named executive officers.

Board of Directors

From the proxy statement filed Apr 28, 2026 · updated by the 8-K of May 6, 2026

Directors
9
serving now
Independent
7 of 9
stated in the proxy
Average tenure
4.6 years
from year joined
CEO also chairs the board
No
Beth A. Brooke
Director Age On board Independent Committees Other public boards 2025 pay Source
Beth A. Brooke
66 2019
7 years
Independent
Standing Committee
New York Times Company $292,870
Derrick A. Duke
59 2025
1 year
Not independent
Strategy Committee · Chair
None stated Paid as CEO
Prama Bhatt
56 2024
2 years
Independent
Standing Committee
JD Sports Fashion Plc $242,870
Todd Arden
59 2025
1 year
Independent
Standing Committee
None stated $182,150
A. John Hass, III
60 2021
5 years
Independent
Standing Committee
None stated $247,870
Francis S. Soistman
69 2021
5 years
Not independent None stated None stated Not stated
Erin L. Russell
52 2021
5 years
Independent
Standing Committee
Fortrea Holdings Inc. $260,370
Dale B. Wolf
72 2019
7 years
Independent
Standing Committee
Molina Healthcare, Inc. $245,370
Andrea C. Brimmer Leaving at the meeting
60 2018
8 years
Independent
Standing Committee
None stated $247,870

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

3 disclosed in the proxy filed Apr 28, 2026
H.I.G. (Echelon Health SPV, LP and affiliated funds)
investment vehicle of H.I.G. Capital, LLC; purchaser of Series A preferred stock in the Private Placement
$225,000,000
2021

Private Placement of 2,250,000 shares of Series A preferred stock to H.I.G. under the H.I.G. Investment Agreement

With Echelon Health SPV, LP Open in proxy
H.I.G. (Echelon Health SPV, LP and affiliated funds)
investment vehicle of H.I.G. Capital, LLC
Amount not stated
2025

First amendment to the H.I.G. Investment Agreement, entered in connection with a revolving credit facility with CCP Agency, LLC, including Strategy Committee rights and governance protections for H.I.G.

With CCP Agency, LLC Open in proxy
Todd Arden
H.I.G. nominee who succeeded Aaron C. Tolson as a director in September 2025
Amount not stated

H.I.G. nominated Todd Arden to the Board under the H.I.G. Investment Agreement and he serves on the Compensation, Nominating and Corporate Governance, and Strategy Committees

With H.I.G. Open in proxy

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support